LC Mobile Phase Research Articles

A liquid chromatography/tandem mass spectrometry method for determination of obatoclax in human plasma.

We describe a selective and highly sensitive high-performance liquid chromatography-electrospray ionization-collision induced dissociation-tandem mass spectrometry (HPLC-ESI-CID-MS/MS) assay for the pan-antiapoptotic Bcl-2 family inhibitor, obatoclax, in human plasma. Fifty μL plasma specimens were prepared by addition of extraction solution consisting of Mobile Phase A (10mM ammonium formate (aq) titrated to pH of 3.0 with formic acid): Mobile Phase B (100% methanol) (20:80, v,v) and internal standard followed by centrifugation. HPLC separations were performed on a Waters, YMC-Pack™, ODS-AQ™ S-3 analytical column with LC mobile phase A and B. Linearity and sensitivity was assessed over a linear range of 0.04-25ng/ml at eleven concentrations. The lower limit of quantification for obatoclax was 0.04ng/mL. The intra-day precision based on the standard deviation of replicates of quality control (QC) samples ranged from 0.9 to 5.1% and the accuracy ranged from 98.9 to 106.8%. Stability studies performed replicate sets of QC samples (0.1ng/mL, 2.5ng/mL, and 15ng/mL) showed that obatoclax in human plasma was stable at room temperature for 24h as well as at -80°C for 1m and 2y. Stability was also demonstrated after 3 freeze/thaw cycles (RT to -80°C). The analytical method showed excellent sensitivity, precision, and accuracy. This method is robust and has been successfully employed in a Children's Oncology Group Phase 1 Consortium study of obatoclax in children with cancer.

Validation for the determination of biuret in water-soluble, urea-based commercial inorganic fertilizer materials, urea solutions, and sulfur-coated urea products by reversed-phase liquid chromatography: single-laboratory validation of an extension of AOAC official methods 2003.14.

A single-laboratory validation (SLV) study for the LC determination of biuret in dry and liquid urea-based commercial fertilizers was conducted. A total of 23 samples were used: 11 commercial dry urea products, two urea ammonium nitrate products, eight liquid urea-based commercial fertilizers, and four sulfur-coated urea samples from different sources. In addition, one biuret standard from Aldrich and one sample from the Magruder check sample program were used as validation samples. The proposed method is an extension of AOAC Official Method 2003.14 and is based on dissolution of the test portion in the LC mobile phase and determination by HPLC. The system is linear over a concentration range of 1.00-4.50 mg/L biuret, with a correlation coefficient > or = 0.9999. The biuret was well- separated from urea in the commercial urea samples, and from other constituents in the commercial liquid fertilizer with no observed interferences. Recoveries were determined by spiking four of the validation materials with a known amount of biuret standard and measuring the biuret level according to the method. The averaged recovery was 97%. Method precision was determined by quadruplicate analyses of four of the liquid and six of the commercially available dry urea validation materials using three and four replicate analyses. For the liquid fertilizer analyses, the RSD ranged from 7.04 to 13.31%. For the dry urea analyses, the RSDs ranged from 5.68 to 14.34%. Instrument precision was evaluated at the test initiation by using seven injections of five biuret standard solutions. SD varied from 0.27 to 1.02%, with RSDs averaging 1.14%. The LOD was determined to be 0.009% biuret in material, while the LOQ was determined to be 0.031% biuret in material. In addition to the intralaboratory study, interlaboratory studies were performed by two other outside laboratories using this method. Over a concentration range of 0.2 to 0.9% biuret, the average SD was 0.11%, the average RSD was 21.16%, and the average HorRat value was 4.73%. Furthermore, comparative studies for biuret using AOAC Official Methods 960.04 and 976.01 with the proposed LC method were performed. The three methods produced very close results; however, the two AOAC methods generate hazardous wastes and are more tedious. On the basis of accuracy and precision of the results for this SLV study, it is recommended that this method be collaboratively studied for the determination of biuret in dry and liquid urea-based commercial fertilizer materials.

Rapid isolation of high solute amounts using an online four-dimensional preparative system: normal phase-liquid chromatography coupled to methyl siloxane-ionic liquid-wax phase gas chromatography.

This study reports the recent evolution of a multidimensional GC-GC-GC preparative system, now combined with an online LC preseparation step, operated under normal phase conditions. It is herein shown that the four-dimensional instrument can collect sample components with a concentration lower than 10%, in a short time period, while maintaining a high level of analyte purity. The LC dimension allows (I) the injection of higher sample amounts, compared to "direct" GC injection; (II) a polarity-based preseparation, leading to the GC injection of simplified subsamples, and thus reducing the possibility of coelutions; (III) to eliminate the essential-oil "matrix", replacing it with the LC mobile phase (the GC system is more protected from potential contamination); (IV) the LC mobile phase is of much lower viscosity with respect to a pure, or highly concentrated essential oil, avoiding difficulties in the syringe sample withdrawal process, prior to GC injection. System optimization was performed by using standard solutions; in addition, a very complex sample, namely, vetiver essential oil, was subjected to the preparative process, with the scope of isolating two low-amount constituents (namely, α-amorphene and β-vetivone). The latter two sesquiterpenoids, which accounted for 1.7 and 4.0% of the sample (considering the volatiles), respectively, were successfully collected at the milligram level, in a one-day work period, with a purity degree in excess of 90%.

Ion-pair reversed-phase liquid chromatography–quadrupole-time-of-flight and triple-quadrupole–mass spectrometry determination of ethyl sulfate in wastewater for alcohol consumption tracing

Ethyl sulfate (EtS) is excreted in urine as a minor metabolite (0.010–0.016% on molar basis) after intake of alcoholic beverages, being a convenient biomarker for ethanol tracing after its determination in sewage. In this work, a new method for the direct determination of EtS in wastewater by liquid chromatography–(tandem) mass spectrometry (LC–MS(/MS)) has been developed. Different LC columns, mobile phases, and detection systems have been tested. Convenient retention by ion-pair reversed-phase LC was achieved by addition of 50mM tetrabutylamonium bromide to the sample. Also, a triple-quadrupole (QqQ) instrument and a quadrupole time-of-flight (QTOF) system were compared. The repeatability of both systems and linearity was comparable, with RSD≤10% in sewage samples. The QqQ instrument provided a better limit of detection (LOD=0.1μgL−1) than the QTOF system LOD (0.2μgL−1). However, the LOD of this last instrument was still good enough for wastewater concentrations, while avoiding problems with interferences on the QqQ not permitting positive identification with this last system. The stability of EtS was tested and it has proven to be stable in wastewater for at least one week at room temperature and more than one month at −20°C. The application of the method to samples collected during a week in a Galician (NW Spain) city showed EtS concentrations between 4 and 12μgL−1. This translated into a per capita consumption of pure ethanol in the range from 9 to 24mLday−1inh−1, observing an increase during the weekend compared to weekdays.

LC-MS/MS method for simultaneous determination of myclobutanil, hexaconazole, diniconazole, epoxiconazole and tetraconazole enantiomers in soil and earthworms

A new method using gel permeation chromatography (GPC) clean-up followed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) was developed for the determination of myclobutanil, hexaconazole, diniconazole, epoxiconazole and tetraconazole enantiomers in soil and earthworms. The soil and earthworm samples were extracted with acetonitrile and then purified with a GPC procedure conducted on a CO785 column with cyclohexane and ethyl acetate (50:50, V/V) as the mobile phase at a flow rate of 4.7 mL/min. The eluent between 7.5 min and 15 min was collected for LC-MS/MS analysis. The LC mobile phase and MS/MS conditions were optimised. Formic acid (0.1%, V/V) was added to the water phase to enhance MS responses. The LODs of the enantiomers were between 0.001–0.003 mg/kg. At three fortification levels of 0.01–1.00 mg/kg, recoveries were between 81.2% and 100.2% in soil and earthworms. The relative standard deviation was below 14%. The results of earthworm experiment showed that hexaconzole and diniconazole might have the bioaccumulation potential, whereas tetraconazole, epoxiconazole and myclobutanil were most likely to undergo enantioselective biotransformation. On the contrary, the degradation of the triazoles in soil was achiral, and less than 10% of them were degraded after 21 days.

Optimization of hydrophilic interaction LC by univariate and multivariate methods and its combination with salting‐out liquid–liquid extraction for the determination of antihypertensive drugs in the environmental waters

Hydrophilic interaction LC for the separation of four antihypertensive drugs was optimized by both univariate and multivariate methods. The column efficiency, resolution, and separation time were used as the three assessment parameters. The best separation condition of 97% ACN with 3% aqueous buffer containing 50 mM ammonium acetate at a pH of 3.0 was obtained by the two optimization methods. The multivariate optimization, orthogonal array design herein, was demonstrated to be a little tedious, but afforded a much better understanding of underlying separation factors. The content of ACN in the mobile phase contributed most significantly to separation. Furthermore, sample diluent and injection volume were found to influence the chromatographic performance. To match the hydrophilic interaction LC mobile phase, a proper sample pretreatment method, salting-out liquid-liquid extraction, in which ACN was the extractant, was chosen. Since reserpine was unstable under both acidic and alkaline conditions, it was not studied in this part. The optimal salting-out liquid-liquid extraction parameters were as follows: 400 μL ACN was added to 1 mL sample solution containing 500 mg NH4 Cl at a pH of 14.0. The linearity ranged from 0.01 to 1.00 μg/mL with r(2) > 0.9937. The LODs were between 1.9 and 2.5 ng/mL. The developed method was applied to the environmental water sample with good performance.

UHPLC-ESI-HRMS Quantitation of Metabolites without Using Reference Standards: Impact of LC Flow Rate and Mobile Phase Composition on MS Responses

During LC-MS quantitation of drugs for pharmacokinetic assessment, usually metabolites are not quantified due to the unavailability of reference standards. If a metabolite is quantified without a reference standard, then it is assumed that the LC-MS response to a drug is similar to that of its metabolite and the standard curve, of the parent compound, is used to quantitate the metabolite. This approach could result in an over or underestimation of the metabolite. To evaluate the impact of mobile phase composition on LC-MS response, the mobile phases were interchanged between methanol, acetonitrile and a 50/50 mixture of methanol/acetonitrile. UHPLC flow rates were varied from 200-500 μL/min, with and without the addition of reverse composition of mobile phases, at the parent drug retention time. This change was necessary to achieve uniform MS responses for drugs and their metabolites. In this study, HRMS data, obtained using orbi-trap, resulted in a linear response over a wider dynamic range than that obtained using the linear ion trap. Overall, the parameters, required for achieving standard free quantitation, are dependent upon the mobile phase composition and LC flow rates.

A new approach based on off‐line coupling of high‐performance liquid chromatography with gas chromatography‐mass spectrometry to determine acrylamide in coffee brew

A new method based on off-line coupling of LC with GC in replacement of conventional sample preparation techniques is proposed to analyze acrylamide in coffee brews. The method involves the preseparation of the sample by LC, the collection of the selected fraction, its concentration under nitrogen, and subsequent analysis by GC coupled with MS. The composition of the LC mobile phase and the flow rate were studied to select those conditions that allowed separation of acrylamide without coeluting compounds. Under the conditions selected recoveries close to 100% were achieved while LODs and LOQs equal to 5 and 10 μg/L for acrylamide in brewed coffee were obtained. The method developed enabled the reliable detection of acrylamide in spiked coffee beverage samples without further clean-up steps or sample manipulation.

Improvement of the sensitivity of 2D LC‐MEKC separation of phenolic acids and flavonoids natural antioxidants using the on‐line preconcentration step

A 2D method was developed for separation of phenolic acids and flavonoids natural antioxidants combining LC with MEKC. The in-capillary preconcentration step was applied for the improvement of the sensitivity of 2D method before the second dimension MEKC analysis. The influence of first dimension LC mobile phase composition on migration times in the second MEKC dimension was evaluated. When gradient elution is applied in the first dimension of 2D LC-MEKC system, increasing concentration of organic solvent in the mobile phase and in fractions transferred from LC influences the electroosmotic flow, partitioning equilibria of samples in micelles and properties of the micelles, which results in shifts of migration times during the consecutive runs in the second MEKC separation dimension. The shifts of migration times caused by the influence of increasing concentration of ACN on MEKC separation in second dimension of 2D LC-MEKC system were compensated by aligning the time axis using electroosmotic flow and micellar marker migration times. The optimized LC-MEKC method was applied on the separation of natural antioxidants in the plant extracts samples.

Detection of gamma-hydroxybutyrate in hair: Validation of GC–MS and LC–MS/MS methods and application to a real case

A gas chromatography-mass spectrometry (GC-MS) and a liquid chromatography tandem mass spectrometry (LC-MS/MS) method were validated for quantifying endogenous and exogenous hair concentrations of gamma-hydroxybutyrate (GHB). The GC-MS method is based on overnight extraction of 25 mg hair in NaOH at 56 °C, liquid/liquid extraction in ethylacetate and trimethylsylil derivatization; analysis is by electron ionization and single ion monitoring of three ions. The LC-MS/MS method entails a rapid digestion of 25 mg hair with NaOH at 75 °C for 40 min, liquid/liquid extraction in ethylacetate and reconstitution of the extract in the LC mobile phase; negative ion electrospray ionization and multiple reaction monitoring (MRM) analysis are employed for the LC-MS/MS detection. In both cases, GHB-d6 is used as an internal standard. The endogenous amount in "blank" hair are estimated by the standard addition method. Limits of detection are 0.4 and 0.5 ng/mg for GC-MS and LC-MS/MS respectively, while the limit of quantification (LOQ) is 0.6 ng/mg for both methods; the GC-MS method proved to be linear in the range 1-50 ng/mg whereas linearity was demonstrated from 0.6 to 50 ng/mg for the LC-MS/MS; imprecision and inaccuracy were always lower than 23% for quality controls samples. The two methods were applied to a real case of a man addicted to GHB; the drug concentration in segments from 17 cm hair strand well correlated with self-reported use of GHB in different periods of his life. Performances of the two methods were similar.

Green Bioanalytical Methods Are Now A Reality

BioanalysisVol. 4, No. 11 Special Focus: Green bioanalysis - ForewordFree AccessGreen bioanalytical methods are now a realityOlivier HeudiOlivier HeudiDMPK/Bioanalytics & Biotechnology Development, Forum 1 Novartis Campus, Novartis Pharma AG, Basel, Switzerland. Search for more papers by this authorEmail the corresponding author at olivier.heudi@novartis.comPublished Online:21 Jun 2012https://doi.org/10.4155/bio.12.112AboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInReddit Keywords: bioanalysisenvironmentgreengreen chemistryThe conclusions of the recent conference on climate held in Durban, South Africa, were not really reassuring with regards to the current state of our planet. In fact several voices have arisen to ask a number of urgent measures in order to preserve our planet by reducing the use of hazardous chemicals and polluting processes in various fields of activity. In this respect, several polluting industries have been designated. Moreover, it has been suggested to claim a financial compensation to the more polluting industries. In the field of chemistry, and particularly the one of bioanalysis, there has been a concern about the use of hazardous chemicals and, thus, new concepts have been developed in order to reduce waste and replace the most polluting solvents. In this respect, the notion of green chemistry has emerged in all steps of bioanalysis, from the sample withdrawal, storage and analysis. Thus, the continuous effort in green bioanalytical methods is reflected by several scientific contributions from a variety of research groups, and it is appropriate that Bioanalysis dedicates a special focus issue to green bioanalytical methods.In the present issue we include a wide selection of research, review and editorial papers focusing on green bioanalytical methods and laboratory practices. The editorial papers discuss new green bioanalytical methods in the drug-discovery and -development field. They put emphasis on sample preparation, with the development of solid-phase microextraction and supercritical fluid chromatography, reduction of sample collection using techniques, such as dried blood spot sampling, and replacement of conventional LC mobile phase, such as acetonitrile by ethanol, which is less polluting. The research papers deal with real examples of green bioanalytical implementation in the field of sample collection, extraction or preparation and analysis (with or without chromatography) as well as reduction of sample size.Overall, it is clear from the articles in this issue that the interest in green bioanalytical methods is growing in the drug-discovery and -development field. Green methods and practices can also lead to more efficient, cost-effective bioanalytical laboratories. In the near future, we will certainly see developments and new methods in this arena. I would like to thank all the authors for their contributions to this issue, and hope that it contributes, in some small way, to improving our environment.Financial & competing interests disclosureThe author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.No writing assistance was utilized in the production of this manuscript.FiguresReferencesRelatedDetailsCited ByUHPLC-MS/MS assay using environment friendly organic solvents: A green approach for fast determination of quetiapine in rat plasmaArabian Journal of Chemistry, Vol. 12, No. 7 Vol. 4, No. 11 Follow us on social media for the latest updates Metrics History Published online 21 June 2012 Published in print June 2012 Information© Future Science LtdKeywordsbioanalysisenvironmentgreengreen chemistryFinancial & competing interests disclosureThe author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.No writing assistance was utilized in the production of this manuscript.PDF download

Mitigation of signal suppression caused by the use of trifluoroacetic acid in liquid chromatography mobile phases during liquid chromatography/mass spectrometry analysis via post‐column addition of ammonium hydroxide

A method has been developed to reduce the mass spectrometric ion signal suppression associated with the use of TFA as an additive in LC mobile phases. Through post-column infusion of diluted NH(4)OH solution to LC eluents, the ammonium ion introduced causes the neutral analyte-TFA ion pair to dissociate which consequently releases the protonated analyte as free ions into the gas phase (through regular electrospray ionization mechanisms). An ion signal improvement from 1.2 to 20 times for a variety of compounds had been achieved through the application of this method. The molar ratios of NH(4)OH:TFA which result in a reduction of signal suppression were determined to be between 0.5:1 and 50:1. In addition, it was shown that this NH(4)OH infusion method could reduce the level of doubly-charged species and the product ions formed via in-source collision. The use of diluted NH(4)OH solution is favorable since it is compatible with mass spectrometry analysis, and it is applicable in both positive and negative-ion generation mode.

Immunoaffinity chromatography purification and ultra-high-performance liquid chromatography-tandem mass spectrometry determination of four β-agonists in beef

A highly selective and sensitive method was developed for the simultaneous determination of four β-agonists (clenbuterol, salbutamol, ractopamine and terbutaline) in beef by immunoaffinity chromatography purification coupled to ultra-high-performance LC-MS/MS. The MS/MS conditions, ultra-high-performance LC mobile phase, injection solution, sample purification process and matrix effect were studied to optimise the operation conditions. The limits of detection (LODs) of the instrument for the studied β-agonists ranged from 0.20 to 0.25 µg l−1, and the LODs of the method for the studied β-agonists ranged from 0.20 to 3.00 µg kg−1 for beef. Calibration curves were constructed using a standard solution diluted with blank beef matrix. The linear ranges of the calibration curves ranged from 5 to 100 µg kg−1 and the coefficients of determination were >0.9942 (n = 10) for all four β-agonists. Samples spiked at 5, 10 and 50 µg kg−1 showed recoveries >72% and RSDs <6.6%. The method is suitable for the simultaneous detection of four β-agonists at trace levels in beef.

Polar aprotic modifiers for chromatographic separation and back-exchange reduction for protein hydrogen/deuterium exchange monitored by Fourier transform ion cyclotron resonance mass spectrometry.

Hydrogen/deuterium exchange monitored by mass spectrometry is an important non-perturbing tool to study protein structure and protein–protein interactions. However, water in the reversed-phase liquid chromatography mobile phase leads to back-exchange of D for H during chromatographic separation of proteolytic peptides following H/D exchange, resulting in incorrect identification of fast-exchanging hydrogens as unexchanged hydrogens. Previously, fast high-performance liquid chromatography (HPLC) and supercritical fluid chromatography have been shown to decrease back-exchange. Here, we show that replacement of up to 40% of the water in the LC mobile phase by the modifiers, dimethylformamide (DMF) and N-methylpyrrolidone (NMP) (i.e., polar organic modifiers that lack rapid exchanging hydrogens), significantly reduces back-exchange. On-line LC micro-ESI FT-ICR MS resolves overlapped proteolytic peptide isotopic distributions, allowing for quantitative determination of the extent of back-exchange. The DMF modified solvent composition also improves chromatographic separation while reducing back-exchange relative to conventional solvent.

Mini Test Dose of Intravenous Busulfan (Busulfex®) in Allogeneic Non-Myeloablative Stem Cell Transplantation, Followed by Liquid Chromatography Tandem-Mass Spectrometry

Abstract 4566 INTRODUCTION:Busulfan (Bu) has been used for almost 3 decades in the conditioning of hematopoietic stem cell transplant. Given orally, Bu exhibits highly variable bioavailability and diverse inter-individual systemic exposure, which prompted various therapeutic drug monitoring approaches. An intravenous (i.v.) formulation was developed to overcome these issues; however 10 to 30% of the adult patients receiving i.v. Bu will not have an AUC within the therapeutic window. Clearly, a need for therapeutic i.v. dose adjustment still persists. Instead of looking into AUC after the 1st therapeutic dose and adjusting the subsequent doses, a safer and potentially more successful approach is to use a sub-therapeutic test dose prior to the conditioning administration and determine a personalized therapeutic dose, maximizing the possibility of achieving an adequate exposure. Beri et al. [1] used a 0.8 mg/kg i.v. test dose (1/4 of the standard daily dose). Without the test dose, 23% of the 17 patients would have fallen below and 12% above the therapeutic range. With the test dose, no patients had a sub-therapeutic AUC and only 12% had an AUC above the therapeutic window.We investigated the bioequivalence of a very low sub-therapeutic test dose (1/10 of the standard daily dose) of i.v. Bu (Busulfex®) in order to reduce the unnecessary exposure and adverse effects of the test dose process. For this purpose we developed a sensitive and fast liquid chromatography tandem-mass spectrometry (LC-MS/MS) method which allowed us to measure Bu in a wide concentration range required in the study. EXPERIMENTAL:Utility of the new LC-MS/MS assay and bioequivalence of the test vs therapeutic regimens were investigated in the “Myeloid Cohort” (patients with a high chance of progressive myeloid diseases, marrow failure syndromes or myeloproliferative disorders) of the ongoing “Efficacy of T-Cell Depleted Allogeneic Non-Myeloablative Stem Cell Transplantation” study. The treatment flow chart is presented in Table 1. During both test and therapeutic Bu regimens, plasma was collected at pre-dose, 15 min, 1, 2, 4, and 24 hrs. To 100 μL of plasma sample, 100 ng of busulfan-d8 (internal standard) was added. After extraction of analytes by ethylacetate, evaporation of the solvent and reconstitution in LC mobile phase, 50 μL of the sample was injected into the LC-MS/MS system. Calibration samples in 1.6 ng/mL – 5 μg/mL range of pure Bu in plasma were run along the study samples. LLOQ of the method (80% accuracy) was 1.6 ng/mL. Pharmacokinetic (PK) parameters were calculated by non-compartmental approach using WinNonlin software.Table 1Treatment flow chartDRUG/DOSEDAY -4DAY -3DAY -2DAY -1DAY 0-4Alemtuzumab (in vivo) 20 mg/dayxxxxFludarabine 40 mg/m2/dayxxxxBusulfan TEST dose 13 mg/m2 (18 min infusion)xBusulfan 130 mg/m2/day (180 min infusion)xxAllogeneic PBSC infusionx RESULTS:Presented here are results from 3 patients infused in consecutive days with 18 min long test dose and 180 min long therapeutic dose. Figure 1 shows a typical plasma Bu conc./time profile. Figure 2 is a semi-log (log conc. vs time) plot illustrating equal terminal slopes (elimination rate, clearance) for both test and therapeutic doses. Table 2 lists AUC values calculated within the boundaries of the PK sample collection time (24 hrs in case of both test and therapeutic regimens) as well as the AUCTEST/AUCTHERAP ratio. [Display omitted] [Display omitted] Table 2PK parametersPK parameterPat. #1Pat. #2Pat. #3AUCTEST (μM·min)447376403AUCTHERAP (μM·min)336731863106AUCTEST/AUCTHERAP7.58.57.7 CONCLUSION:The newly developed LC-MS/MS assay proved to be optimal in terms of concentration range (1.6 ng/mL – 5 μg/mL), throughput (4 min per analytical run), and small sample size (100 μL plasma). PK calculations (AUC) show: 1) low inter-patient variability in both test and therapeutic doses and 2) promising value of the test dose in predicting exposure by the therapeutic dose (stable AUCTEST/AUCTHERAP ratio) although larger number of subjects is needed for accurate assessment. Disclosures:Spasojevic:Otsuka America Pharmaceuticals, Inc.: Research Funding. Horwitz:Otsuka America Pharmaceuticals, Inc.: Honoraria. Rizzieri:Otsuka America Pharmaceuticals, Inc.: Research Funding.

Effect of nicotine on cytochrome P450 1A2 activity

Effect of nicotine on cytochrome P450 1A2 activity

A Role for Prolyl 3-Hydroxylase 2 in Post-translational Modification of Fibril-forming Collagens

The fibrillar collagen types I, II, and V/XI have recently been shown to have partially 3-hydroxylated proline (3Hyp) residues at sites other than the established primary Pro-986 site in the collagen triple helical domain. These sites showed tissue specificity in degree of hydroxylation and a pattern of D-periodic spacing. This suggested a contributory role in fibril supramolecular assembly. The sites in clade A fibrillar α1(II), α2(V), and α1(I) collagen chains share common features with known prolyl 3-hydroxylase 2 (P3H2) substrate sites in α1(IV) chains implying a role for this enzyme. We pursued this possibility using the Swarm rat chondrosarcoma cell line (RCS-LTC) found to express high levels of P3H2 mRNA. Mass spectrometry determined that all the additional candidate 3Hyp substrate sites in the pN type II collagen made by these cells were highly hydroxylated. In RNA interference experiments, P3H2 protein synthesis was suppressed coordinately with prolyl 3-hydroxylation at Pro-944, Pro-707, and the C-terminal GPP repeat of the pNα1(II) chain, but Pro-986 remained fully hydroxylated. Furthermore, when P3H2 expression was turned off, as seen naturally in cultured SAOS-2 osteosarcoma cells, full 3Hyp occupancy at Pro-986 in α1(I) chains was unaffected, whereas 3-hydroxylation of residue Pro-944 in the α2(V) chain was largely lost, and 3-hydroxylation of Pro-707 in α2(V) and α2(I) chains were sharply reduced. The results imply that P3H2 has preferred substrate sequences among the classes of 3Hyp sites in clade A collagen chains.

P.1.c.060 (±)3,4-Methylenedioxyamphetamine inhibits a TEA-sensitive potassium current in the hippocampus

The detection and quantitation of drugs of abuse in blood is of growing interest in forensic and clinical toxicology. With the development of highly sensitive chromatographic methods, such as high-performance liquid chromatography (HPLC) with sensitive detectors and gas chromatography–mass spectrometry (GC–MS), more and more substances can be determined in blood. This review includes methods for the determination of the most commonly occurring illicit drugs and their metabolites, which are important for the assessment of drug abuse: Methamphetamine, amphetamine, 3,4-methylenedioxymethamphetamine (MDMA), N-ethyl-3,4-methylenedioxyamphetamine (MDEA), 3,4-methylenedioxy-amphetamine (MDA), cannabinoids (delta-9-tetrahydrocannabinol, 11-hydroxy-delta-9-tetrahydrocannabinol, 11-nor-9-carboxy-delta-9-tetrahydrocannabinol), cocaine, benzoylecgonine, ecgonine methyl ester, cocaethylene and the opiates (heroin, 6-monoacetylmorphine, morphine, codeine and dihydrocodeine). A number of drugs/drug metabolites that are structurally close to these substances are included in the tables. Basic information about the biosample assayed, work-up, GC column or LC column and mobile phase, detection mode, reference data and validation data of each procedure is summarized in the tables. Examples of typical applications are presented.

Monolithic integration of two-dimensional liquid chromatography-capillary electrophoresis and electrospray ionization on a microfluidic device.

A microfluidic device capable of two-dimensional reversed-phase liquid chromatography-capillary electrophoresis with integrated electrospray ionization (LC-CE-ESI) for mass spectrometry (MS)-based proteomic applications is described. Traditional instrumentation was used for the LC sample injection and delivery of the LC mobile phase. The glass microfabricated device incorporated a sample-trapping region and an LC channel packed with reversed-phase particles. Rapid electrokinetic injections of the LC effluent into the CE dimension were performed at a cross-channel intersection. The CE separation channel terminated at a corner of the square device, which functioned as an integrated electrospray tip. In addition to LC-CE-ESI, this device was used for LC-ESI without any instrumental modifications. To evaluate the system, LC-MS and LC-CE-MS analyses of protein digests were performed and compared.

High-Sensitivity Method for Determination of Tetrabromobisphenol-S and Tetrabromobisphenol-A Derivative Flame Retardants in Great Lakes Herring Gull Eggs by Liquid Chromatography−Atmospheric Pressure Photoionization−Tandem Mass Spectrometry

Tetrabromobisphenol-A-bis(2,3-dibromopylether) (TBBP-A-dbpe), tetrabromobisphenol-A-bis(allyl ether) (TBBP-A-ae), and tetrabromobisphenol-S-bis(2,3-dibromopropyl ether) (TBBP-S-dbpe) are derivatives of tetrabromobisphenol-A (TBBP-A), and are all used as brominated flame retardants (BFRs). Using high-performance liquid chromatography-quadrupole-time-of-flight-mass spectrometry with atmospheric pressure photoionization (APPI) in the negative mode (LC-APPI(-)-Q-TOF-MS) and the novel use of pure acetone as dopant and LC mobile phase, full scan mass spectra showed that for these BFRs the dominant isotopic ion cluster was [M + O₂](-), and with other lesser abundant [M + O₂ - HBr](-), and [M - H](-) fragment ions. Subsequently, highly sensitive quantification of TBBP-A-dbpe, TBBP-A-ae, and TBBP-S-dbpe was accomplished via LC-triple quadrupole mass spectrometry with APPI(-) (LC-APPI(-)-MS/MS) via multiple ion monitoring based on the [M + O₂](-) > [Br](-) transition. Low to sub ng/g (wet weight (w.w.)) method limits of detection (LODs) were achieved, i.e., 0.07, 0.03, and 1.28 ng/g w.w. for TBBP-A-dbpe, TBBP-A-ae, and TBBP-S-dbpe, respectively. A variety of herring gull eggs were screened for these BFRs. The eggs were collected during 2008-2009 from several colony sites in the eastern Laurentian Great Lakes (Ontario) and in the St. Lawrence River (Québec). All egg samples had TBBP-S-dbpe concentrations below the LOD, and TBBP-A-ae and TBBP-A-dbpe were quantifiable in 67%-83% of the samples at concentrations up to 0.56 ng/g wet weight. Thus, TBBP-A-ae and TBBP-A-dbpe are present in herring gull eggs from these populations, bioaccumulate in the herring gull food chain, and are transferred from gull to egg.